Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (171-180 of 261) with videos related to

Pageof 27
Sort By:
Cancer Causes & Control : CCC|April 26, 2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohortAnneli Essén, Aida Santaolalla, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breastLars Holmberg, Hans Garmo, Bengt Granstrand, et al.
BMC Public Health|July 20, 2013
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
Nutrition and Cancer|December 12, 2013
Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish menErika Ax, Hans Garmo, Birgitta Grundmark, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
Scandinavian Journal of Urology|May 20, 2025
Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based studyPaolo Zaurito, Hans Garmo, Rolf Gedeborg, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 27

Showing results (171-180 of 261) with videos related to

Sort By:
Pageof 27
Cancer Causes & Control : CCC|April 26, 2019
Baseline serum folate, vitamin B12 and the risk of prostate and breast cancer using data from the Swedish AMORIS cohortAnneli Essén, Aida Santaolalla, Hans Garmo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 6, 2008
Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breastLars Holmberg, Hans Garmo, Bengt Granstrand, et al.
BMC Public Health|July 20, 2013
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS studyWahyu Wulaningsih, Karl Michaelsson, Hans Garmo, et al.
Nutrition and Cancer|December 12, 2013
Dietary patterns and prostate cancer risk: report from the population based ULSAM cohort study of Swedish menErika Ax, Hans Garmo, Birgitta Grundmark, et al.
BJU International|September 24, 2017
Drugs for metabolic conditions and prostate cancer death in men on GnRH agonistsCecilia Bosco, Chloe Wong, Hans Garmo, et al.
Scandinavian Journal of Urology|May 20, 2025
Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based studyPaolo Zaurito, Hans Garmo, Rolf Gedeborg, et al.
Cancer Causes & Control : CCC|May 8, 2013
Iron metabolism and risk of cancer in the Swedish AMORIS studyAnjali Gaur, Helen Collins, Wahyu Wulaningsih, et al.
European Urology|December 1, 2018
Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate CancerKerri Beckmann, Hans Garmo, Jan Adolfsson, et al.
Carcinogenesis|July 2, 2015
Prediagnostic serum inflammatory markers in relation to breast cancer risk, severity at diagnosis and survival in breast cancer patientsWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
International Journal of Cancer|May 11, 2018
Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitusChristel Häggström, Mieke Van Hemelrijck, Hans Garmo, et al.
Pageof 27